Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Will UnitedHealth's (UNH) Benefits Business Aid Q3 Earnings?

Published 10/14/2019, 08:05 AM
Updated 07/09/2023, 06:31 AM

UnitedHealth Group Inc.’s (NYSE:UNH) health service segment UnitedHealthcare is likely to have performed well in the third quarter, which may reflect on the quarterly results, slated for release on Oct 15.

UnitedHealthcare benefits business has been a major contributor to the company’s top-line growth.

In the last reported quarter, revenues from UnitedHealthcare grew 6.1% year over year. Revenue growth was driven by higher enrollment and increase in pricing. All the business groups – Employer and Individual, Medicare and Retirement and Community and State contributed to the growth. Earnings from operations were up 12.1% year over year to $2.6 billion, led by revenue growth and cost control.

Click here to know how the company’s overall third-quarter performance is expected to be.

Let’s Delve Deeper

UnitedHealthcare has consistently witnessed balanced growth, serving increasingly diverse markets. Among these growing market segments are Medicaid, including people needing long-term services and support and dual eligible individuals; seniors, including Medicare Advantage and Part D plans, as well as employer sponsored retiree groups; large national employers, along with medium and small employer groups; and emerging markets, like global health benefits, social services, personalized wellness and caregiver services.

The segment is likely to have seen an increase in membership in the third quarter, primarily as a result of acquisitions and growth in services to self-funded employers and seniors.

Within UnitedHeathcare, fee-based commercial group business should have benefitted from an acquisition.

Revenues from Medicare Advantage business is likely to show an increase due to growth in people served through individual and employer-sponsored group Medicare Advantage plans.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

UnitedHealthcare Community & State revenues should have gained from growth in people served with higher acuity needs.

The segment’s operating earnings should have benefitted from operating cost management.

Zacks Rank & Key Picks

Currently, UnitedHealth carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the broader healthcare sector include Molina Healthcare, Inc. (NYSE:MOH) , Cigna Corp. (NYSE:CI) and HCA Healthcare, Inc. (NYSE:HCA) . While Molina sports a Zacks Rank #1 (Strong Buy), Cigna and HCA Healthcare carry a Zacks Rank of 2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Long-term earnings growth for Molina Healthcare, Cigna and HCA Healthcare is currently projected at 9.6%, 11.7% and 11.3%, respectively.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>









Cigna Corporation (CI): Free Stock Analysis Report

Molina Healthcare, Inc (MOH): Free Stock Analysis Report

UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report

HCA Healthcare, Inc. (HCA): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.